Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes

E-ISSN： 1875-5453|16|10|877-893

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.16, Iss.10, 2015-12, pp. : 877-893

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 236-241

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

Current Drug Metabolism, Vol. 11, Iss. 7, 2010-09 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor

By Yeboah D. Sun M. Kingdom J. Baczyk D. Lye S.J. Matthews S.G. Gibb W.

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1251-1258

NRC Research Press

Access to resources Recommend Favorite

Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity

By Gunness Patrina Aleksa Katarina Koren Gideon

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 9, 2011-07 ,pp. : 675-680

NRC Research Press

Access to resources Recommend Favorite

Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer

By Saladores Pilar H Precht Jana C Schroth Werner Brauch Hiltrud Schwab Matthias

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 4, 2013-05 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite